Myriad Genetics stock plunges after UnitedHealth Group announces they will no longer cover genetic tests for mental health ...

Recent advances in genetic testing technology have transformed personal health care from general guidelines to precise, ...

SALT LAKE CITY, Nov. 04, 2024 (GLOBE NEWSWIRE) -- , (NASDAQ: MYGN), a leader in genetic testing and precision medicine, was ...

Three years ago, the DNA-testing firm 23andMe was a massive success ... Secondly, plans to use an anonymised version of the ...

Discussions about ethics are important in many aspects of health care but are especially critical when the health care includes genetic testing. There are several aspects of genetic testing that ...

A growing body of research describes seasonal trends in psychiatric ... interaction tests, tail suspension tests (TSTs), and ...

Living Local 15 host Jessica Williams is joined by Sean Goddard, a Psychiatric Nurse Practitioner and Owner of Viking Psychiatry, to discuss the Gene Testing they offer and how it can help your ...

Testing your DNA is easier than ever with an abundance of at-home DNA tests on the market. All you need to do is provide a simple DNA sample to learn more about your heritage and family history.

Myriad Genetics said it is in talks with UnitedHealthcare to ensure that enrollees continue to have access to its GeneSight mental health medication test after the insurer changed its coverage policy.

In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...

Myriad Genetics (MYGN) was informed on Friday, November 1, 2024, of an updated medical policy from UnitedHealthcare restricting access to ...